DDI-DrugBank.d736.s0 >> Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability). >> 90-98
DDI-DrugBank.d736.s1 >> Hypokalemia may develop during concomitant use of steroids or ACTH. >> 50-57,62-65
DDI-DrugBank.d736.s2 >> Insulin requirements in diabetic patients may be increased, decreased, or unchanged. >> 0-6
DDI-DrugBank.d736.s3 >> Thiazides may decrease arterial responsiveness to norepinephrine. >> 0-8,50-63
DDI-DrugBank.d736.s4 >> This diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.
DDI-DrugBank.d736.s5 >> Thiazide drugs may increase the responsiveness of tubocurarine. >> 0-13,50-61
DDI-DrugBank.d736.s6 >> Lithium renal clearance is reduced by thiazides, increasing the risk of lithium toxicity. >> 0-6,38-46,72-78
DDI-DrugBank.d736.s7 >> Thiazides may add to or potentiate the action of other antihypertensive drugs. >> 0-8,55-76
DDI-DrugBank.d736.s8 >> Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs. >> 25-34;50-74,39-74
